Recent guidance on COVID-19 in light of the state of emergency declared in New York State. Issued 3/7/20. Revised 3/11/20

NYS Department of Health has issued additional Medicaid pharmacy guidance regarding the declared Disaster Emergency in the State of New York over COVID-19.

A tri-agency letter outlining Hep A preventive measures from the New York State Department of Health (NYS DOH), the Office of Addiction Services and Supports (NYS OASAS)...

OASAS guidance to Opioid Treatment Programs regarding the coronavirus (COVID-19). Issued March 10, 2020.

NYS Department of Health guidance on and criteria for discontinuation of quarantine of patients with COVID-19. Issued March 9, 2020.

Guidance for group or residential treatment settings on the cleaning and disinfection of frequently touched areas in congregate (non-treatment) settings (e.g., door handles, handrails, shared telephones/computers). 

Guidance form NYS DOH regarding recent emergency regulations authorizing second-tier syringe exchange programs.

The FDA has now approved two effective and distinct co-formulated antiviral agents for the prevention of HIV acquisition in adults and adolescents. Health insurance plans...

SAMHSA letter reminding providers of the importance of providing HIV testing. OASAS regulations require HIV testing either on-site or by referral.

Update from NYS Department of Health Commissioner Dr. Howard Zucker. 9/2019